JeffreyGroup announced today a partnership with Pfizer Inc. to execute a far-reaching public health campaign across 12 Latin American countries. In response to a growing burden facing adults who suffer from pneumococcal disease, Pfizer aims to educate Latin Americans about the ease and effectiveness of vaccines for adults over the age of 50. JeffreyGroup was selected in a competitive search to help lead the effort.
“With approximately 125,000 Latin Americans over the age of 50 dying each year from pneumococcal disease, we felt it was critical to lead an aggressive awareness campaign to help educate the public about their prevention options,” said Mark Partridge, Emerging Markets Business Unit, Vaccines. “With that in mind, it was just as critical to choose the right partner with demonstrated healthcare expertise in the complex Latin American regulatory environment and proven creativity that ultimately leads to results. We’re happy to say we found a match with JeffreyGroup.”
The campaign puts the spotlight squarely on awareness and prevention, taking a completely unbranded approach to public health marketing. Elements include a trilingual website, social media management, testimonial videos, key opinion leader outreach, consumer events, community outreach and traditional media relations.
”We’re honored to be partnering with an industry leader like Pfizer on such a critical public health mission,” said Mike Valdes-Fauli, President of JeffreyGroup.